LEMON TREE HOTELS LTD
LEMONTREE.NS NSELemon Tree Hotels Ltd looks about 25% undervalued against its cash-flow value. Its growth outlook scores strong; the balance sheet is solid.
At a glance
tap a tile to dig inOtto's verdict
the tiles above, in a line each- Value Looks ~25% undervalued against Otto's cash-flow estimate.
- Health 12 of 15 health checks pass.
- Growth Revenue trend ≈ +15%/yr (extended trend, not a forecast).
- Street Analysts lean strong buy · avg target +39% from here.
- Dividend No dividend — this is a growth-only story.
Not investment advice — Otto just crunches numbers.
Price trend
-30.4% over one year · NIFTY 50 -3.2%
What think
The market's move: -30.4% over the past year
Trading 11% up its 52-week range. Price is the market's live vote — not advice.
Analyst consensus: Strong Buy · 22 analysts
Average 12-month target $1.58 — +39.3% vs today.
Yahoo Finance's analyst aggregate. Sentiment, not advice.
Insider filings come from SEC EDGAR — US companies only, so there's none for LEMONTREE.NS.
InvestRight readers: 0 watching
This site's own activity — not a broad measure. Sentiment, not advice.
The snowflake
checks passed on each axis- Value 2/2 checks
- Future 4/4 checks
- Past 2/3 checks
- Health 4/6 checks
- Dividend 0/— checks
What does this show?
Five quick health scores — Value, Future, Past, Health and Dividend — each 0–100%. A bigger, more even shape means a stock that scores well across the board; a spiky one is strong on some axes and weak on others.
Learn more on Investopedia →Fair value
our estimate · not analyst forecast25% below our estimate — you'd be paying less than our numbers say it's worth.
How we got there
A 2-stage discounted-cash-flow on free cash flow: grow it at the capped historical trend for five years, fade to a 2.5% long-run rate, discount everything at 9.0%. It's a transparent estimate from past numbers, not a licensed forecast — treat it as one lens, not truth.
What does this show?
Our estimate of what one share is worth based on the cash the business is expected to generate (a discounted-cash-flow model), next to today's price. Below fair value hints undervalued, above hints expensive — it's an estimate, not a guarantee.
Learn more on Investopedia →Health checks
15 checks run on free data- ⚠ Debt is under 40% of equity debt/equity 96%
- ⚠ Growth accelerating vs its average latest 15.5%/yr vs 25.6% average
- ⚠ Short-term assets cover long-term debt 4.3B vs 18.5B
- ✓ Trading below our fair-value estimate +25% vs our DCF estimate
- ✓ Debt/equity falling over time long-term debt/equity 94.2% vs 177.7%
- ✓ Debt well covered by cash flow operating cash flow covers 27.0% of debt
Show all 15 checks by axis
Value 2/2 passed
- ✓ Trading below our fair-value estimate +25% vs our DCF estimate
- – P/B below industry industry P/B not on the free feed
- – P/E below industry industry P/E not on the free feed
- – P/E below peer average peer P/Es land after the next refresh
- – P/S sane vs its own history needs multi-year P/S (Tier B)
- ✓ More than 20% below fair value +25% margin of safety
Future 4/4 passed
- ✓ Earnings trending up 25.6%/yr over 3yr
- – Growth beats the industry industry growth not on the free feed
- ✓ Earnings growth beats the market 25.6%/yr vs market ~9.0%
- ✓ Revenue trending up 19.8%/yr over 3yr
- ✓ Return on equity improving ROE 16.3% vs 13.4% 3yr ago
Past 2/3 passed
- ✓ Earnings grew over the period 1.1B → 2.3B
- – High-quality earnings (few one-offs) one-off detection deferred — needs statement detail
- ⚠ Growth accelerating vs its average latest 15.5%/yr vs 25.6% average
- ✓ Revenue higher than five years ago 8.4B → 14.4B
- – Return on equity above 20%
Health 4/6 passed
- ✓ Debt/equity falling over time long-term debt/equity 94.2% vs 177.7%
- ⚠ Debt is under 40% of equity debt/equity 96%
- ✓ Debt well covered by cash flow operating cash flow covers 27.0% of debt
- ✓ Interest comfortably covered by profit EBIT covers interest 3.0×
- ⚠ Short-term assets cover long-term debt 4.3B vs 18.5B
- ✓ Short-term assets cover short-term bills 4.3B vs 3.5B
Dividend 0/— passed
- – Dividend covered by earnings and cash flow pays no dividend
- – Dividend growing over time pays no dividend
- – No dividend cut in recent years pays no dividend
- – Payout ratio under 75% pays no dividend
- – Yield beats the market pays no dividend
- – Yield in the top quartile of payers pays no dividend
What does this show?
Pass/fail rules on the company's finances — debt levels, profitability, cash cover and so on. More greens means a sturdier balance sheet; an n/a just means we didn't have that data point.
Learn more on Investopedia →Past performance
recent history from Yahoo FinanceRevenue
Earnings
Free cash flow
dashed line = what it'd look like growing at our ~9% market-average benchmark, for comparison
Deeper 10-yr statements are US-only for now — Otto's showing LEMONTREE.NS's Yahoo figures instead.
What does this show?
How revenue, earnings and free cash flow have grown over the years. Bars rising left-to-right show a growing business; the dashed line is a market-average pace for comparison.
Learn more on Investopedia →Revenue & expenses
FY 2026What does this show?
How a company turns sales into profit. Revenue splits into the direct cost of sales and the gross profit left over; from that gross profit come operating costs (R&D, SG&A), tax and interest — what survives is net income. Every figure is also shown as a share of revenue, so you can compare periods and companies of different sizes.
Learn more on Investopedia →Future
trend, not analyst forecastRevenue · extended at 15.0%/yr
Earnings · extended at 15.0%/yr
Dashed bars just extend the historical trend (capped at ±15%/yr) — the same growth our DCF uses. It's arithmetic on the past, not an analyst forecast; real futures bend.
What does this show?
Solid bars are history; dashed bars simply extend the past growth trend a few years forward — capped so it stays sane. It's a trend line, not an analyst forecast.
Learn more on Investopedia →Dividend
from cash actually paid, not promisesLEMON doesn't pay a dividend — Otto leaves this axis blank rather than guessing.
What does this show?
The share of profit paid back to shareholders as cash. Yield is that cash as a % of the price; the payout gauge shows how much of earnings is paid out (over ~75% can be hard to sustain).
Learn more on Investopedia →Ownership & insiders
Insider-trade filings come from SEC EDGAR, which covers US companies only — there's no free equivalent for Indian filings yet, so Otto skips this one for LEMONTREE.NS.
What does this show?
Buys and sells by the company's own directors and officers, from their SEC filings. Insiders sell for many reasons, but clusters of open-market buying can signal confidence.
Learn more on Investopedia →Spot a missing competitor? Sign in to add it — it'll show for everyone.
What does this show?
A few peers in the same business, each with its own mini snowflake, so you can see how this company stacks up rather than judging it in isolation. Anyone signed in can add a missing competitor — it shows for everyone, marked as user-added.
Learn more on Investopedia →Leadership
Yahoo Finance · photos & bios via Wikidata-
Mr. Ajai Kumar
Senior VP & Chief Information Officer
Indian oncologist and entrepreneur
- Age
- 57
- Education
- University of Virginia
Ranked by title — reporting lines aren't public data. Compensation is the total Yahoo reports; blank means it isn't disclosed there.
In the news
- Lemon Tree signs 110-key hotel in Visakhapatnam, India
- Lemon Tree Hotels Ltd (BOM:541233) (Q1 2027) Earnings Call Highlights: Strategic Pivot to ...
- Lemon Tree Hotels Ltd (BOM:541233) Q4 2026 Earnings Call Highlights: Record Revenue and ...
- CCI clears Coastal Cedar’s stake purchase in Fleur Hotels
- Lemon Tree Hotels signs agreement for new Lonavala resort in Maharashtra
- India's Lemon Tree Hotels plans overseas push amid outbound travel surge
- Lemon Tree Hotels Ltd (BOM:541233) Q3 2026 Earnings Call Highlights: Record Revenue and ...
- Warburg Pincus to buy 41% stake in Lemon Tree Hotels unit Fleur Hotels
My notes
Sign in to keep a private decision journal on this stock — only you can see your notes.
Hi! I can explain LEMON's numbers — valuation, health, the dividend, the fair-value gap. What would you like to know?
Otto explains what's on this page — not investment advice.